Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicininduced injury of cardiomyocytes - Izumi, M; Masaki, M; Hiramoto, Y (J Mol Cell Cardiol, 2006)
et al.